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OBJECTIVES We sought to assess the right heart’s response to percutaneous device closure of moderate
sized atrial septal defects (ASDs) in adults over a one-year follow-up period.
BACKGROUND Percutaneous ASD device closure is a safe and effective means of reducing or eliminating
interatrial shunting. The response of the adult’s right heart to device closure is incompletely
understood.
METHODS Forty consecutive patients had 40 device implantations (32 with the CardioSeal implant and
8 with the Amplatzer device). The patients were assessed with echocardiography, chest
radiography and electrocardiography before the procedure and at 1, 6 and 12 months.
RESULTS The mean ASD size was 13 6 4 mm, and the device size ranged from 33 to 40 mm for
CardioSeal and 12 to 36 mm for Amplatzer. At one month, heart size (49% vs. 46%),
four-chamber right ventricular (RV) size (45 vs. 41 mm), paradoxical septal motion (60% vs.
5%), QRS duration (125 vs. 119 ms), PR interval (181 vs. 155 ms) and echocardiographically
determined pulmonary artery systolic pressure decreased significantly and was maintained at
12-month follow-up. At six months, right atrial length decreased from 50 to 47 mm. At one
year, 29% of patients had persistent RV enlargement.
CONCLUSIONS Right heart morphology undergoes rapid improvement within one month of defect closure,
with associated mechanoelectrical benefit. A small number of patients had persistent RV
enlargement or pulmonary hypertension, or both, at one year. Our data support the
application of transcatheter methods in achieving excellent hemodynamic and anatomic
outcomes. (J Am Coll Cardiol 2001;37:2108–13) © 2001 by the American College of
Cardiology
Atrial septal defects (ASDs) account for 10% of all congen-
ital heart lesions (1) and represent the third most common
congenital cardiac defect seen in adults (2). This lesion is
sometimes associated with the development of pulmonary
hypertension, congestive heart failure, atrial arrhythmias
and impaired aerobic capacity, corresponding with varying
degrees of right heart volume overload and decompensation
(3–5). Such potential complications have prompted prophy-
lactic closure during childhood or early adulthood. In the
later adult years, ASD closure provides symptomatic relief
and may prevent the progression of right heart dysfunction
(4). Both surgical and catheter occlusion of the defect has
been found effective and safe in reducing left to right
shunting (6,7). In addition, transcatheter ASD closure has
the advantage of avoiding the need for sternotomy, cardio-
pulmonary bypass and intensive care stay and permits rapid
patient recovery, with its associated economic and social
benefits (8). However, the response of the adult’s right
ventricle (RV) after percutaneous defect closure is incom-
pletely understood, with the degree and rate of resolution of
RV enlargement, pulmonary hypertension and paradoxical
septal motion (PSM) remaining unclear in this group of
patients. The focus of this investigation was to describe
changes in RV physiology over a one-year follow-up period
in adults who had undergone catheter device closure of an
isolated ASD.
METHODS
Patients. Forty consecutive adults underwent secundum
ASD device closure at the Toronto General Hospital
between April 1, 1997 and December 31, 1999. The
functional classes (New York Heart Association) of the
patients are summarized in Table 1. Only one patient had
documented paroxysmal atrial fibrillation. All patients un-
derwent chest radiography, echocardiography and 12-lead
electrocardiography before the procedure and at 1, 6 and 12
months after the procedure. Echocardiography was per-
formed using a standardized protocol by a single senior
sonographer (H.E.H.). Echocardiographic, electrocardio-
graphic (ECG) and chest radiographic data were reviewed
retrospectively.
Device design and implantation. A CardioSeal implant
(Nitinol Medical Technologies Inc., Boston, Massachu-
setts) was used in 33 patients, and an Amplatzer occluder
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(AGA Medical, Golden Valley, Minnesota) was used in 8
patients. The CardioSeal implant consists of four flexible
spring-loaded stainless-steel arms covered by two Dacron
patches (8). The Amplatzer device, on the other hand,
consists of a Nitinol meshwork that assumes a double
mushroom shape when deployed, with the central portion of
the complex plugging the defect (9). The indication for
defect closure in all patients was an increased RV end-
diastolic diameter on the echocardiogram or an enlarged
heart on the chest radiograph, or both, with or without the
presence of symptoms. The procedures were performed
under general anesthesia with fluoroscopic and transesoph-
ageal echocardiographic guidance. Access was obtained
from the femoral vein. A sizing balloon catheter (Meditech
Boston Scientific, Mansfield, Massachusetts, or Amplatzer
sizing balloon, AGA Medical) was used to determine the
so-called stretched diameter of the defect. A suitably sized
device was chosen to be twice the size (CardioSeal) or the
same size (Amplatzer) as the stretched diameter. The
devices were deployed through long sheaths (9F to 11F)
using previously described techniques (6).
Two-dimensional echocardiography. All patients under-
went transesophageal echocardiography to assess their suit-
ability for the device and subsequently only transthoracic
studies, as part of the clinical follow-up. All available
transthoracic studies were reviewed retrospectively, and the
measurements were verified by an experienced echocardiog-
rapher (G.R.V.). On-line measurements were made in the
parasternal, apical four-chamber and subcostal views to
define the RV and right atrial (RA) sizes, presence of PSM,
defect size and number, position and presence of residual
shunts after defect closure. Four-chamber views were ob-
tained to document the maximal RV inlet diameter at end
diastole, with measurements made at the tips of the tricus-
pid valve leaflets. On the parasternal long-axis view, the
right ventricular outflow tract diameter (RVOTD) was
determined as the widest short-axis RVOTD. Four-
chamber views were obtained to measure RA size, using the
maximal mediolateral diameter (width), as well as the
maximal superoinferior diameter (length) of the atrium,
(10,11) measured at end systole (Fig. 1). The parasternal
long-axis and short-axis views were studied for the presence
of paradoxical motion of the interventricular septum. When
PSM was evident on any of these views, it was denoted as
being present.
Residual shunts were defined by their cross-sectional
diameter on the color flow map. Color Doppler settings,
including the velocity map scale, were kept constant
throughout all studies by the sonographer (H.E.H.) per-
forming the investigation. All echocardiographic studies
were performed on the same machine. For accurate shunt
identification, multiple echocardiographic views were exam-
ined. The widest diameter on any view was identified as the
residual shunt size. Shunts were arbitrarily defined as small
(,3 mm), moderate (3 to 6 mm) and large (.6 mm) in size.
Right ventricular systolic pressure was estimated from tri-
cuspid regurgitation jet velocity, when present (12). All
repeat on-line measurements were performed using a
Hewlett-Packard Sonos 2500 echocardiograph.
Chest radiography. All patients underwent posteroanterior
chest radiography, and cardiac size was expressed as a
percentage of the total thoracic diameter.
Electrocardiography. Twelve-lead surface ECGs were an-
alyzed for the mean frontal plane QRS axis, the widest QRS
duration (from the initial deflection of the QRS complex to
where the terminal deflection crosses the baseline, taken in
any chest lead with the widest complex and where the
deflections are acute enough to permit accurate assessment
[expressed in milliseconds]), the presence of RA overload
(defined by any combination of peaked p waves, p wave
height .2.5 mm in any lead or p wave .1.5 mm in lead
Abbreviations and Acronyms
ASD 5 atrial septal defect
ECG 5 electrocardiogram or electrocardiographic
PA 5 pulmonary artery
PSM 5 paradoxical septal motion
RA 5 right atrium or atrial
RV 5 right ventricle or ventricular
RVOTD 5 right ventricular outflow tract diameter
Figure 1. Echocardiographic measurement of RA dimensions at end
systole. A7B 5 maximal mediolateral dimension (i.e., width of RA);
C7D 5 superoinferior dimension (i.e., length of RA); LA 5 left atrium;
LV 5 left ventricle; RA 5 right atrium; RV 5 right ventricle.
Table 1. Intraobserver Variability*
RV dimensions 4.8%
RA dimensions 6.5%
PR interval 4.3%
QRS duration 8.8%
QRS axis 5%
Cardiothoracic ratio 4%
*Expressed as a percentage of the standard deviation of the difference between initial
and repeat measurements on the same variable, divided by the mean value of the two
measurements.
RA 5 right atrial; RV 5 right ventricular.
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V2), the PR interval (measured from the initial deflection of
the p wave to the initial deflection of the QRS complex), the
R wave height in lead V1 (height of initial positive deflec-
tion of the QRS complex above the baseline value [ex-
pressed in millimeters]) and the presence of right bundle
branch block (defined by the presence of an “rSR” pattern in
lead V1 or V2). A single observer made all ECG and
radiographic measurements (V.R.).
Statistics. Data are presented as the mean value 6 SD for
normally distributed data obtained before the procedure and
at 1, 6 and 12 months after the procedure. Echocardio-
graphic, ECG and chest radiographic variables at each
follow-up period were compared with the preprocedural
values; categorical data were presented as a proportion of the
total number of patients who had data available during the
follow-up period. Continuous variables were compared
using paired t tests. Categorical variables were compared
using either the chi-square or Fisher exact test, as appro-
priate. For comparisons of the continuous variables (RV size
and pulmonary artery [PA] pressure) between patients ,40
years old and those $40 years old, an independent t test was
used. For comparisons between baseline and follow-up
measurements, the level of significance was adjusted for
multiple comparisons (p 5 0.05/3 5 0.017). To document
intraobserver variability, repeat measurements were done in
randomly selected patients. A single observer, who had no
knowledge of the previous measurements for a particular
patient, repeated 30% of ECG, radiographic and echocar-
diographic measurements on the same study. Intraobserver
variability was expressed as a percentage of the standard
deviation of the difference between initial and repeat mea-
surements on the same study, divided by the mean value of
the two measurements. Our study protocol was deemed
ethical by the local Research Ethics Board.
RESULTS
Forty devices were successfully deployed in 40 patients.
Their ages ranged from 20 to 71 years (median 38). The
female to male ratio was 3:1. Mean ASD diameter was 13 6
4 mm, and the balloon size stretched at the time of
catheterization to 17 6 3 mm. The device size ranged from
33 to 40 mm (median 40) for the CardioSeal implant and 12
to 40 mm (median 23) for the Amplatzer device. Thirty-
eight patients had 1-month, 36 patients 6-month and 28
patients had 12-month follow-up.
Immediately after device closure, residual shunts were
detected in 29 patients (73%), 28 occurring in those patients
with a CardioSeal device. Residual interatrial shunts oc-
curred in 21 patients (53%) at one month, 18 patients (50%)
at six months and 14 patients (54%) at one year. Residual
shunt sizes ranged from 2 to 8 mm (median 5) (Fig. 2).
Functional class improved after defect closure (Fig. 3).
Electrocardiographic analysis revealed a significant de-
crease in the PR interval (181 6 8 vs. 155 6 2 ms, p ,
0.001) and QRS duration (125 6 2 vs. 119 6 2 ms, p 5
0.001) at one month, and at six months, RA overload
became reduced significantly to 0% (p , 0.001). The mean
frontal plane QRS axis declined from 63 6 33° to 54 6 26°
(p 5 0.027) at six months, reaching significance at one year
(57 6 21°, p , 0.001). R-wave height in lead V1 did not
change significantly during the one-year follow-up.
On the echocardiogram, mean four-chamber RV size and
mean RVOTD decreased significantly by one month to
within the normal limits (45 6 8 vs. 41 6 6 mm, p , 0.001
and 39 6 7 vs. 34 6 5 mm, p 5 0.004, respectively); normal
ranges for four-chamber RV size and RVOTD were 26 to
43 mm and 18 to 34 mm, respectively (10). At one year, 8
(29%) of 28 patients had an enlarged RV (four-chamber
view), compared with 23 (62%) of 37, before ASD closure
(p . 0.001). At one-year, the size and incidence of residual
interatrial shunts did not differ between those who had an
enlarged postprocedural RV and those who did not have an
enlarged RV. Mean right atrial length (superoinferior di-
ameter) showed a trend toward shortening at one month
(52 6 7 vs. 50 6 6 mm, p 5 0.081) and reached significance
at six months (47 6 5 mm, p , 0.001). Normal values for
RA length are indicated in Table 2 (10). Right atrial width
(mediolateral diameter) did not change significantly with
Figure 2. Size of residual shunts over follow-up time.
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time. Estimated systolic PA pressures also followed a
progressive course of decline in the first year after the
procedure, achieving significance at one month (Table 2).
Before the procedure, 23 (62%) of 37 patients had systolic
PA pressures .35 mm Hg; at one month, 17 (45%) of 38
patients, at six months, 9 (27%) of 33 patients and at 12
months, only 8 (29%) of 28 patients had systolic PA
pressures elevated .35 mm Hg. Patients .40 years old at
the time of device implantation had significantly higher
systolic PA pressures before ASD closure (42 6 11 vs. 31 6
8 mm Hg, p 5 0.001) and one year later (41 6 4 vs. 31 6
12 mm Hg, p 5 0.032). Four-chamber RV size did not
differ significantly, however. Paradoxical septal motion was
present in 21 (58%) of 36 patients before implantation, 2
(5%) of 37 patients at one month, 4 (12%) of 33 patients at
six months and in none at 12 months. The results are
summarized in Table 2.
Intraobserver variability. The data are summarized in
Table 1.
DISCUSSION
Despite the preponderance of residual atrial shunts, these
data demonstrate that in the adult patient with a moderate
sized secundum ASD, there is a significant decrease in
cardiac size by one month after catheter closure. Closure of
the ASD results in volume unloading of the right heart and
an early reduction in cardiac size. The RV size continued to
decline so that the mean size on the four-chamber view was
within normal limits at one month and was maintained at 6
and 12 months. At one-year follow-up, only a third of
patients demonstrated persistent RV enlargement. Berger et
al. (13) demonstrated a reduction in end-diastolic RV
volume on the echocardiogram early after device closure in
23 patients, as well as in 24 patients after surgical ASD
closure, similar to the findings we demonstrated at one
month. They did not examine RA size. Gatzoulis et al. (5)
demonstrated a significant reduction in the cardiothoracic
ratio three to six months after surgical ASD closure; in
Figure 3. Distribution of New York Heart Association (NYHA) functional classes over duration of follow-up. Mon 5 interval (months) between procedure
and follow-up date; Pre 5 before atrial septal defect closure.
Table 2. Summary of All Data
Before
Procedure 1 Month p Value 6 Months p Value 1 Year p Value
CTR (%) 49 6 7 46 6 7 , 0.001* 47 6 8 , 0.001* 48 6 7 , 0.001*
RA overload on ECG 4/33 (12%) 3/36 (8.3%) 0.385 0/32 , 0.001* 0/25 , 0.001*
QRS axis 63 6 33° 60 6 28° 0.027 54 6 26° 0.027 57 6 21° , 0.001*
PR interval (ms) 181 6 8 155 6 2 , 0.001* 151 6 2 0.061 147 6 2 , 0.001*
QRS duration (ms) 125 6 2 119 6 2 0.001* 109 6 1 , 0.001* 104 6 1 , 0.001*
R wave in lead V1 (mm) 2.5 6 1.5 2.4 6 1.7 0.769 2.3 6 1.6 0.413 1.8 6 1.3 0.413
RV size (mm)
Four-chamber normal 26–43 45 6 8 41 6 6 0.003* 37 6 5 , 0.001* 37 6 6 , 0.001*
RVOTD (mm)
Normal 18–34 39 6 7 34 6 5 0.004* 33 6 6 0.001* 33 6 6 0.066
RA length (mm)
Normal 34–49 52 6 7 50 6 6 0.081 47 6 5 , 0.001* 47 6 6 0.027
Patients with PSM 21/36 (60%) 2/37 (5%) , 0.001* 4/33 (12%) , 0.001* 0/27 , 0.001*
Systolic PA pressure .35 mm Hg 23/37 (62%) 17/38 (45%) 0.016* 9/33 (27%) , 0.001* 8/27 (29%) , 0.001*
*Significant p values. The p values reflect pairwise comparisons between preprocedure and follow-up measurements. Data are presented as the mean value 6 SD or number (%)
of patients.
CTR 5 cardiothoracic ratio; PA 5 pulmonary artery; PSM 5 paradoxical septal motion; RA 5 right atrial; RV 5 right ventricular; RVOTD 5 right ventricular outflow
tract diameter.
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addition, they demonstrated an initial increase in the cardio-
thoracic ratio early after repair, believed to be related to
cardiopulmonary bypass, which was not evident in our non-
surgical cohort.
In some ventricles with prolonged volume loading, RV
morphology does not completely return to normal (14,15).
In our study, 29% of patients had persistent RV enlarge-
ment at one year. Pearlman et al. (14) investigated this
phenomenon of persistent RV enlargement after ASD
closure in a surgical cohort of 31 patients. Similar to our
group, 23% of their patients had persistent RV enlargement
and tended to be older patients (i.e., .25 years old at the
time of operation). Despite the fact that 95% of our cohort
was .25 years old, most RVs returned to normal size by one
year in a time-related manner. Those who had persistent
RV enlargement tended to be .40 years at the time of
device implantation, suggesting an impaired ability of the
RV to remodel after prolonged volume loading, or the aged
state per se. We were unable to demonstrate a relationship
between the incidence and size of residual interatrial shunts
and the persistence of RV enlargement. Pearlman et al. (14)
also demonstrated that only one of their study patients
had a significant residual left to right shunt on oximetry, and
they concluded that residual shunts did not contribute to the
observed persistent right heart abnormality. During the first
six months after ASD closure, there was a corresponding
significant decline in the presence of RA overload, PR
interval and QRS duration on the ECG. These mechano-
electrical changes presumably reflect better intra-atrial and
intraventricular conduction properties subsequent to volume
unloading of both right heart chambers and may potentially
reduce the substrate for late atrial arrhythmia (3), as has
been demonstrated in patients with a partial right heart
bypass and single-ventricle physiology (16). Gatzoulis et al.
(5), in their adult surgical cohort, also demonstrated an early
reduction in the QRS duration, but did not report changes
in the PR interval or RA enlargement by ECG criteria.
Abnormal septal motion began to normalize by one
month in a significant percentage of patients, and the
process continued over the one-year follow-up period.
Abnormal septal wall motion is caused by displacement of
the interventricular septum toward the left ventricle, as the
RV becomes progressively volume-loaded (1). During ven-
tricular systole, the septum moves “paradoxically” toward
the RV as the left ventricle contracts. An abrupt reduction
in RV volume is most likely responsible for the restoration
of normal wall motion. This process may not be complete,
and some authors have demonstrated permanent changes in
RV wall motion abnormality (14,15).
A reduction in estimated systolic PA pressures also
followed a progressive normalizing trend. By one year, only
29% of patients had pressures elevated .35 mm Hg. At late
follow-up, Oelberg et al. (12) demonstrated persistent
elevation in rest systolic PA pressures in 16% of their
patients, and some patients only demonstrated abnormal
elevation of PA pressures during exercise. These findings
suggest a proportion of patients have permanently elevated
pulmonary vascular resistance before ASD closure.
Intraobserver variability. We have documented accurately
the degree of intraobserver variability for echocardiographic,
radiographic and ECG measurements. Intraobserver vari-
ability was ,10% for all of the echocardiographic and
radiographic measurements, with the greatest variability
demonstrated in RA measurements (6.5%). Right atrial
dimensions, however, decreased by .10% at six months,
more than that expected by chance alone. Intraobserver
variability was ,5% for all ECG measures, with the
exception of QRS duration, which was 8.8%. Despite this
higher variability, QRS duration had declined by 10% at six
months and 16% at one year, again more than anticipated by
variability alone. We therefore believe that the decline in
echocardiographic, ECG and radiographic dimensions re-
flects a true improvement in right heart size.
Study limitations. This study was a retrospective analysis
using echocardiographic, ECG and radiographic means to
describe changes in right heart physiology after device closure
of an ASD. Because of the nongeometric shape of the RV,
quantitation of RV volume is difficult by echocardiography.
Thus, RV dimensions are utilized as a surrogate for RV size.
Our data were collected over a one-year period only, and
during that time, considerable normalization in virtually all
variables was demonstrated. Longer follow-up is imperative to
elucidate further changes in RV physiology. Larger multicenter
patient cohorts would permit more detailed assessment of risk
factors for impaired RV remodeling late after ASD closure.
Conclusions. In adults undergoing transcatheter ASD clo-
sure, there was a significant reduction in RA and RV sizes
and PSM, with corresponding mechanoelectric improvement
in the PR interval, ECG RA overload pattern, mean frontal
plane QRS axis and QRS duration early after the procedure.
Systolic PA pressures followed a slower decline over one year.
Twenty-nine percent of patients demonstrated persistent ele-
vation of PA pressures (they tended to be .40 years of age).
Similarly, 29% of patients had impaired right heart remodeling
at one year, corresponding to published data on patients who
have undergone surgical repair. We conclude that device
closure of ASDs in adults leads to early improvement, with
subsequent continued improvement in RV and RA physiology.
We believe our data support the increasing practice and body
of knowledge in support of nonsurgical closure of isolated
secundum ASDs in selected adults.
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